1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
37,00,000 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 36.36 | 41.19 | 23.63 |
| Total Income | 40.86 | 33.30 | 23.15 |
| Profit After Tax | 4.87 | 5.17 | 3.83 |
| NET Worth | 28.99 | 13.42 | 9.24 |
| Reserves and Surplus | 18.83 | 12.42 | 8.24 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹158.00 |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹36.50 |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹166.00 |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹270.00 |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹307.70 |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹198.35 |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹339.90 |
| Symbiotec Pharmalab Ltd. | Mainboard | ₹1,757.00 Cr | ₹988 | 55.44 | ₹1,097.70 | +11.10% | ₹1,133.45 |
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹67.99 |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹523.35 |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,236.10 |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,835.40 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of Plant & Machinery for Setting up of Cold Storage Facility | 4.42 |
| 2 | Design, Development & Maintenance of Mobile Application | 3.98 |
| 3 | Advertisement and Digital Marketing Activities | 0.66 |
| 4 | Working Capital Requirements | 21.37 |
| 5 | General Corporate Purposes |
About GNH India Pharmaceuticals IPO
Updated on May 19, 2026
Contact Details
GNH India Pharmaceuticals Ltd. AddressUnit No.14, 15, 16, 17, Ground Floor, PrabhadeviIndustrial Estate, Enterprises Industrial Premises408, Veer Sawarkar Road, Prabhadevi,Mumbai, Maharashtra, 400025022-62706900info@gnhindia.comVisit Website